Related references
Note: Only part of the references are listed.Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?
Hans Carl Hasselbalch
BLOOD (2012)
Therapy of chronic myeloid leukaemia can benefit from the activation of stem cells: simulation studies of different treatment combinations
I. Glauche et al.
BRITISH JOURNAL OF CANCER (2012)
Novel insights into the molecular mechanisms of HLA class I abnormalities
Barbara Seliger
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
MHC class I molecules act as tumor suppressor genes regulating the cell cycle gene expression, invasion and intrinsic tumorigenicity of melanoma cells
Cristina Garrido et al.
CARCINOGENESIS (2012)
Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis
Vibe Skov et al.
EXPERIMENTAL HEMATOLOGY (2012)
Biological therapy and the immune system in patients with chronic myeloid leukemia
Peter Rohon
INTERNATIONAL JOURNAL OF HEMATOLOGY (2012)
Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: Identification of deregulated genes of significance for inflammation and immune surveillance
Vibe Skov et al.
LEUKEMIA RESEARCH (2012)
The role of classical and non-classical HLA class I antigens in human tumors
Juergen Bukur et al.
SEMINARS IN CANCER BIOLOGY (2012)
DNA Hypermethylation and Inflammatory Markers in Incident Japanese Dialysis Patients
Sawako Kato et al.
NEPHRON EXTRA (2012)
Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study
Henrik Frederiksen et al.
BLOOD (2011)
The renaissance of interferon therapy for the treatment of myeloid malignancies
Jean-Jacques Kiladjian et al.
BLOOD (2011)
Increase in circulating CD4+CD25+Foxp3+ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-α
Caroline Hasselbalch Riley et al.
BLOOD (2011)
Whole-blood transcriptional profiling of interferon-inducible genes identifies highly upregulated IFI27 in primary myelofibrosis
Vibe Skov et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2011)
A new era for IFN-α in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms
Hans Carl Hasselbalch
EXPERT REVIEW OF HEMATOLOGY (2011)
Recent advances on the immunomodulatory effects of IFN-α: Implications for cancer immunotherapy and autoimmunity
Paola Rizza et al.
AUTOIMMUNITY (2010)
Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM)
Sylvain Thepot et al.
BLOOD (2010)
Efficacious Immune Therapy in Chronic Myelogenous Leukemia (CML) Recognizes Antigens That Are Expressed on CML Progenitor Cells
Melinda A. Biernacki et al.
CANCER RESEARCH (2010)
Transcriptional Profiling of Polycythemia Vera Identifies Gene Expression Patterns Both Dependent and Independent from the Action of JAK2V617F
Windy Berkofsky-Fessler et al.
CLINICAL CANCER RESEARCH (2010)
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells
A. Pellagatti et al.
LEUKEMIA (2010)
Hypermethylation of HLA class I gene is associated with HLA class I down-regulation in human gastric cancer
Q. Ye et al.
TISSUE ANTIGENS (2010)
Increased Risk of Lymphoid Neoplasms in Patients with Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
Alessandro M. Vannucchi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete hematological remission
Thomas Stauffer Larsen et al.
HEMATOLOGY (2009)
The histone deacetylase inhibitor ITF2357 selectively targets cells bearing mutated JAK2V617F
V. Guerini et al.
LEUKEMIA (2008)
Interferon-α and cancer:: Mechanisms of action and new perspectives of clinical use
Maria Ferrantini et al.
BIOCHIMIE (2007)
Impact of inflammation on epigenetic DNA methylation -: a novel risk factor for cardiovascular disease?
P. Stenvinkel et al.
JOURNAL OF INTERNAL MEDICINE (2007)
Mechanisms of disease: The myeloproliferative disorders
Peter J. Campbell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Interferon α and T-cell responses in chronic myeloid leukemia
A Burchert et al.
LEUKEMIA & LYMPHOMA (2005)
Analysis of HLA class Ia transcripts in human leukaemias
D Majumder et al.
IMMUNOGENETICS (2005)
Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack?
C Demanet et al.
BLOOD (2004)
IFN-α promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatment
L Gabriele et al.
BLOOD (2004)
Immunological effects of interferon-alpha on chronic myelogenous leukemia
FA de Castro et al.
LEUKEMIA & LYMPHOMA (2003)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
The anti-tumor activities of interferon (IFN)-α in chronic myelogenous leukaemia (CML)-derived cell lines depends on the IFN-α subtypes
Y Yanai et al.
CANCER LETTERS (2002)
Loss or downregulation of HLA class I expression at the allelic level in acute leukemia is infrequent but functionally relevant, and can be restored by interferon
RE Brouwer et al.
HUMAN IMMUNOLOGY (2002)
Expression of HLA class I antigens and restoration of antigen-specific ctl response in melanoma cells following 5-aza-2′-deoxycytidine treatment
A Serrano et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas
Y Nie et al.
CARCINOGENESIS (2001)
Share Paper
